Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen

Published:2009-06-22 Issue:2 Volume:45 Page:249-253
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Beri R,Chunduri S,Sweiss K,Peace D J,Mactal-Haaf C,Dobogai L C,Shord S,Quigley J G,Chen Y H,Mahmud N,Rondelli D

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009133.pdf

Reference20 articles.

1. Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J et al. Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. Blood 2003; 102: 820–826.

2. Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C . Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood 2003; 102: 3912–3918.

3. Anderson BS, Madden T, Tran HT, Hu WW, Blume KG, Chow DS . Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study. Biol Blood Marrow Transplant 2000; 6: 548–554.

4. Fernandez HF, Tran HT, Federico A, Lennon S, Caldera H, Goodman MS . Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice daily or daily schedule to patients with advanced hematology malignant disease undergoing stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 486–492.

5. Madden T, De Lima M, Thapar N, Nguyen J, Roberson S, Couriel D . Pharmacokinetics of once daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6 h dosing schedule. Biol Blood Marrow Transplant 2007; 13: 56–64.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test‐Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients;The Journal of Clinical Pharmacology;2023-06-09

2. Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation;International Journal of Hematology;2021-09-14

3. Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience;Experimental and Clinical Transplantation;2020-06

4. Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2019-02

5. Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?;Leukemia & Lymphoma;2019-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3